EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases

Donia Jerab iD, Ferdinand Blangero, Paulo César Trindade da Costa iD, José Luiz de Brito Alves iD, Rym Kefi, Henda Jamoussi, Beatrice Morio iD, Assia Eljaafari iD

Nutrients · 03.04.2025 · 17 (7) · 1253

DOI: 10.3390/nu17071253 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 03.04.2025. Verfasst von Donia Jerab und 7 weiteren Autor:innen. Beteiligte Einrichtung: CarMeN Laboratory, Institut National de Recherche pour l' Agriculture, l' Alimentation et l'Environnement, UMR1397, Institut National de la Santé et …. Hauptthemen laut MEDLINE: Fatty Acids, Omega-3, Obesity, Inflammation, Metabolic Diseases. Die Arbeit wurde bisher 61-mal zitiert (Crossref) und nennt 208 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Groupe Lipide et nutrition, Groupe Lipides et Nutrition (GLN), MobiDoc 941 managed by the ANPR under the EU SWAFY project.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Omega-3 polyunsaturated fatty acids (n-3 PUFAs) are known to help resolve inflammation through generation of anti-inflammatory eicosanoids and specialized pro-resolving mediators, including resolvins, protectins, and maresins. Through binding to the GPR120/FFAR4 receptor, their beneficial effects result from phospholipid membrane remodeling, impairment of inflammatory signaling molecules clustering, subsequent inhibition of NF-κB and inflammasome activation, and a reduction in oxidative stress. Obesity, a chronic inflammatory disease that contributes to metabolic disorders, is alleviated by n-3 PUFAs. In the adipose tissue (AT) of individuals with obesity, n-3 PUFAs counteract hypoxia, inhibit immune cell infiltration and AT inflammation, improve insulin sensitivity, and reduce fat mass. Beyond AT, n-3 PUFAs also alleviate other metabolic disorders such as metabolic-associated steatotic liver disease (MASLD), gut dysbiosis, and/or renal dysfunction. In cardiovascular disease (CVD), they are mainly recommended as a secondary prevention for patients with coronary heart disease risks. This review provides an in-depth analysis of the benefits of n-3 PUFAs in obesity and related metabolic diseases, examining both the mechanistic and clinical aspects. Additionally, it also explores the effects of n-3 PUFAs in obesity-related chronic inflammatory conditions, including inflammatory bowel disease, psoriasis, rheumatoid arthritis, osteoarthritis, and multiple sclerosis, by targeting specific pathophysiological mechanisms. Clinical applications and limitations of n-3 PUFAs are discussed based on findings from human clinical trials.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Fatty Acids, Omega-3ObesityInflammationMetabolic DiseasesHumansAdipose TissueChronic DiseaseAnimals

Stichwörter der Autor:innen

Th17 cellschronic metabolic diseasesinflammationinflammatory bowel diseasemultiple sclerosisobesityomega-3 polyunsaturated fatty acidspsoriasisrheumatoid arthritis

Substanzen

Fatty Acids, Omega-3

Autor:innen und Institutionen

  • CarMeN Laboratory, Institut National de Recherche pour l' Agriculture, l' Alimentation et l'Environnement, UMR1397, Institut National de la Santé et de la Recherche Médicale, U 1060, Université Claude Bernard Lyon I, 69…
  • Laboratory of Biomedical Genomics and Oncogenetics, Institut Pasteur de Tunis, Tunis 1002, Tunisia.
  • Department of Nutrition, Health Sciences Center, Federal University of Paraíba, João Pessoa 58051-900, Brazil.
  • Research Unit "Obesity: Etiopathology and Treatment, UR18ES01", Faculty of Medicine, Tunis El Manar University, Tunis 2092, Tunisia.
  • Department of Clinical Research, Hospices Civils de Lyon, 69002 Lyon, France.

ORCID-Profile: Donia Jerab, Paulo César Trindade da Costa, José Luiz de Brito Alves, Beatrice Morio, Assia Eljaafari

Förderung

  • Groupe Lipide et nutrition
  • Groupe Lipides et Nutrition (GLN)
  • MobiDoc 941 managed by the ANPR under the EU SWAFY project

Zitieren

APA

Jerab, D., Blangero, F., da Costa, P. C. T., de Brito Alves, J. L., Kefi, R., Jamoussi, H., Morio, B., & Eljaafari, A. (2025). Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases. Nutrients, 17(7), 1253. https://doi.org/10.3390/nu17071253

Vancouver

Jerab D, Blangero F, da Costa PCT, de Brito Alves JL, Kefi R, Jamoussi H, et al. Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases. Nutrients. 2025;17(7):1253. doi:10.3390/nu17071253

BibTeX
@article{Jerab2025,
  author = {Jerab, Donia and Blangero, Ferdinand and da Costa, Paulo César Trindade and de Brito Alves, José Luiz and Kefi, Rym and Jamoussi, Henda and Morio, Beatrice and Eljaafari, Assia},
  title = {Beneficial Effects of Omega-3 Fatty Acids on Obesity and Related Metabolic and Chronic Inflammatory Diseases},
  journal = {Nutrients},
  year = {2025},
  volume = {17},
  number = {7},
  pages = {1253},
  doi = {10.3390/nu17071253}
}
Kostenlos starten →